HEADER TRANSFERASE 07-AUG-14 4UVN TITLE CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-3-(4- TITLE 2 CHLOROPHENYL)-1,2-DIHYDROISOQUINOLIN-1-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TANKYRASE-2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: C-TERMINAL FRAGMENT, RESIDUES 946-1162; COMPND 5 SYNONYM: TANK2, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 6, ARTD COMPND 6 6, POLY ADP-RIBOSE POLYMERASE 5B, TNKS-2, TRF1-INTERACTING ANKYRIN - COMPND 7 RELATED ADP-RIBOSE POLYMERASE 2, TANKYRASE II, TANKYRASE-LIKE COMPND 8 PROTEIN, TANKYRASE-RELATED PROTEIN; COMPND 9 EC: 2.4.2.30; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_VARIANT: ROSETTA 2; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS TRANSFERASE, PROTEIN-LIGAND COMPLEX, DIPHTHERIA TOXIN LIKE FOLD, ADP- KEYWDS 2 RIBOSYLATION, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.NARWAL,T.HAIKARAINEN,L.LEHTIO REVDAT 5 10-JAN-24 4UVN 1 REMARK LINK REVDAT 4 06-FEB-19 4UVN 1 REMARK REVDAT 3 30-JAN-19 4UVN 1 REMARK REVDAT 2 16-SEP-15 4UVN 1 JRNL REVDAT 1 29-JUL-15 4UVN 0 JRNL AUTH H.A.PAINE,A.NATHUBHAI,E.C.Y.WOON,P.T.SUNDERLAND,P.J.WOOD, JRNL AUTH 2 M.F.MAHON,M.D.LLOYD,A.S.THOMPSON,T.HAIKARAINEN,M.NARWAL, JRNL AUTH 3 L.LEHTIO,M.D.THREADGILL JRNL TITL EXPLORATION OF THE NICOTINAMIDE-BINDING SITE OF THE JRNL TITL 2 TANKYRASES, IDENTIFYING 3-ARYLISOQUINOLIN-1-ONES AS POTENT JRNL TITL 3 AND SELECTIVE INHIBITORS IN VITRO. JRNL REF BIOORG.MED.CHEM. V. 23 5891 2015 JRNL REFN ISSN 0968-0896 JRNL PMID 26189030 JRNL DOI 10.1016/J.BMC.2015.06.061 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.35 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 24996 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1316 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1865 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2290 REMARK 3 BIN FREE R VALUE SET COUNT : 98 REMARK 3 BIN FREE R VALUE : 0.3100 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3354 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 77 REMARK 3 SOLVENT ATOMS : 280 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.01000 REMARK 3 B22 (A**2) : -1.32000 REMARK 3 B33 (A**2) : 1.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.253 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.207 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.136 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.289 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3564 ; 0.013 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): 2475 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4802 ; 1.354 ; 1.952 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5930 ; 0.837 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 423 ; 6.607 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 183 ;31.690 ;22.787 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 587 ;13.724 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;14.639 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 471 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3991 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 785 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2092 ; 0.688 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 872 ; 0.144 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3351 ; 1.295 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1472 ; 1.936 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1449 ; 3.142 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4UVN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1290061464. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93340 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26312 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.8500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.26 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.59000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.270 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3KR7 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M LISO4, 0.1 M TRIS HCL, 22% REMARK 280 PEG3350, PH 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 59.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 59.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 45.34500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 49.07500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 45.34500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 49.07500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 59.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 45.34500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 49.07500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 59.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 45.34500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 49.07500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B2059 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 923 REMARK 465 HIS A 924 REMARK 465 HIS A 925 REMARK 465 HIS A 926 REMARK 465 HIS A 927 REMARK 465 HIS A 928 REMARK 465 HIS A 929 REMARK 465 SER A 930 REMARK 465 SER A 931 REMARK 465 GLY A 932 REMARK 465 VAL A 933 REMARK 465 ASP A 934 REMARK 465 LEU A 935 REMARK 465 GLY A 936 REMARK 465 THR A 937 REMARK 465 GLU A 938 REMARK 465 ASN A 939 REMARK 465 LEU A 940 REMARK 465 TYR A 941 REMARK 465 PHE A 942 REMARK 465 GLN A 943 REMARK 465 SER A 944 REMARK 465 MET A 945 REMARK 465 LEU A 946 REMARK 465 ASN A 947 REMARK 465 THR A 948 REMARK 465 SER A 949 REMARK 465 GLY A 950 REMARK 465 SER A 951 REMARK 465 LYS A 1114 REMARK 465 GLY A 1162 REMARK 465 MET B 923 REMARK 465 HIS B 924 REMARK 465 HIS B 925 REMARK 465 HIS B 926 REMARK 465 HIS B 927 REMARK 465 HIS B 928 REMARK 465 HIS B 929 REMARK 465 SER B 930 REMARK 465 SER B 931 REMARK 465 GLY B 932 REMARK 465 VAL B 933 REMARK 465 ASP B 934 REMARK 465 LEU B 935 REMARK 465 GLY B 936 REMARK 465 THR B 937 REMARK 465 GLU B 938 REMARK 465 ASN B 939 REMARK 465 LEU B 940 REMARK 465 TYR B 941 REMARK 465 PHE B 942 REMARK 465 GLN B 943 REMARK 465 SER B 944 REMARK 465 MET B 945 REMARK 465 LEU B 946 REMARK 465 ASN B 947 REMARK 465 THR B 948 REMARK 465 SER B 949 REMARK 465 GLY B 950 REMARK 465 SER B 951 REMARK 465 LYS B 1114 REMARK 465 GLY B 1162 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A1020 49.14 -146.96 REMARK 500 SER A1130 104.94 30.16 REMARK 500 VAL A1131 -55.12 -154.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 1130 VAL A 1131 147.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A2162 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A1081 SG REMARK 620 2 HIS A1084 ND1 108.8 REMARK 620 3 CYS A1089 SG 114.5 102.5 REMARK 620 4 CYS A1092 SG 114.7 103.3 111.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B2162 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B1081 SG REMARK 620 2 HIS B1084 ND1 106.1 REMARK 620 3 CYS B1089 SG 109.5 104.6 REMARK 620 4 CYS B1092 SG 116.5 103.6 115.1 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 2162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 2162 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 2165 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2163 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 2164 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDJ A 2166 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CDJ B 2165 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 2167 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 2166 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UVL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-1,2- REMARK 900 DIHYDROISOQUINOLIN-1-ONE REMARK 900 RELATED ID: 4UVO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-3-(4- REMARK 900 METHOXYPHENYL)-1,2-DIHYDROISOQUINOLIN-1 -ONE REMARK 900 RELATED ID: 4UVP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-3- REMARK 900 ETHYL-1,2-DIHYDROISOQUINOLIN-1-ONE REMARK 900 RELATED ID: 4UVS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-3- REMARK 900 PENTYL-1,2-DIHYDROISOQUINOLIN-1-ONE REMARK 900 RELATED ID: 4UVT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-4- REMARK 900 METHYL-1,2-DIHYDROISOQUINOLIN-1-ONE REMARK 900 RELATED ID: 4UVU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 1-((4-(5- REMARK 900 METHYL-1-OXO-1,2-DIHYDROISOQUINOLIN-3- YL)PHENYL)METHYL)PYRROLIDIN- REMARK 900 1-IUM REMARK 900 RELATED ID: 4UVV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 3-(4- REMARK 900 CHLOROPHENYL)-5-METHYL-1,2-DIHYDROISOQUINOLIN-1 -ONE REMARK 900 RELATED ID: 4UVW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4,5-DIMETHYL- REMARK 900 3-PHENYL-1,2-DIHYDROISOQUINOLIN-1-ONE REMARK 900 RELATED ID: 4UVX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 3-(4- REMARK 900 CHLOROPHENYL)-5-FLUORO-1,2-DIHYDROISOQUINOLIN-1 -ONE REMARK 900 RELATED ID: 4UVY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 3-(4- REMARK 900 CHLOROPHENYL)-5-METHOXY-1,2- DIHYDROISOQUINOLIN- 1-ONE REMARK 900 RELATED ID: 4UVZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-3- REMARK 900 PHENYL-1,2-DIHYDROISOQUINOLIN-1-ONE DBREF 4UVN A 946 1162 UNP Q9H2K2 TNKS2_HUMAN 946 1162 DBREF 4UVN B 946 1162 UNP Q9H2K2 TNKS2_HUMAN 946 1162 SEQADV 4UVN MET A 923 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS A 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS A 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS A 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS A 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS A 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS A 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN SER A 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN SER A 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLY A 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN VAL A 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN ASP A 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN LEU A 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLY A 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN THR A 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLU A 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN ASN A 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN LEU A 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN TYR A 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN PHE A 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLN A 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN SER A 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN MET A 945 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN MET B 923 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS B 924 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS B 925 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS B 926 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS B 927 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS B 928 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN HIS B 929 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN SER B 930 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN SER B 931 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLY B 932 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN VAL B 933 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN ASP B 934 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN LEU B 935 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLY B 936 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN THR B 937 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLU B 938 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN ASN B 939 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN LEU B 940 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN TYR B 941 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN PHE B 942 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN GLN B 943 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN SER B 944 UNP Q9H2K2 EXPRESSION TAG SEQADV 4UVN MET B 945 UNP Q9H2K2 EXPRESSION TAG SEQRES 1 A 240 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 240 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 A 240 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 A 240 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 A 240 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 A 240 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 A 240 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 A 240 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 A 240 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 A 240 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 A 240 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 A 240 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 A 240 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 A 240 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 A 240 LYS SER PHE LEU GLN PHE SER ALA MET LYS MET ALA HIS SEQRES 16 A 240 SER PRO PRO GLY HIS HIS SER VAL THR GLY ARG PRO SER SEQRES 17 A 240 VAL ASN GLY LEU ALA LEU ALA GLU TYR VAL ILE TYR ARG SEQRES 18 A 240 GLY GLU GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN SEQRES 19 A 240 ILE MET ARG PRO GLU GLY SEQRES 1 B 240 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 B 240 GLY THR GLU ASN LEU TYR PHE GLN SER MET LEU ASN THR SEQRES 3 B 240 SER GLY SER GLY THR ILE LEU ILE ASP LEU SER PRO ASP SEQRES 4 B 240 ASP LYS GLU PHE GLN SER VAL GLU GLU GLU MET GLN SER SEQRES 5 B 240 THR VAL ARG GLU HIS ARG ASP GLY GLY HIS ALA GLY GLY SEQRES 6 B 240 ILE PHE ASN ARG TYR ASN ILE LEU LYS ILE GLN LYS VAL SEQRES 7 B 240 CYS ASN LYS LYS LEU TRP GLU ARG TYR THR HIS ARG ARG SEQRES 8 B 240 LYS GLU VAL SER GLU GLU ASN HIS ASN HIS ALA ASN GLU SEQRES 9 B 240 ARG MET LEU PHE HIS GLY SER PRO PHE VAL ASN ALA ILE SEQRES 10 B 240 ILE HIS LYS GLY PHE ASP GLU ARG HIS ALA TYR ILE GLY SEQRES 11 B 240 GLY MET PHE GLY ALA GLY ILE TYR PHE ALA GLU ASN SER SEQRES 12 B 240 SER LYS SER ASN GLN TYR VAL TYR GLY ILE GLY GLY GLY SEQRES 13 B 240 THR GLY CYS PRO VAL HIS LYS ASP ARG SER CYS TYR ILE SEQRES 14 B 240 CYS HIS ARG GLN LEU LEU PHE CYS ARG VAL THR LEU GLY SEQRES 15 B 240 LYS SER PHE LEU GLN PHE SER ALA MET LYS MET ALA HIS SEQRES 16 B 240 SER PRO PRO GLY HIS HIS SER VAL THR GLY ARG PRO SER SEQRES 17 B 240 VAL ASN GLY LEU ALA LEU ALA GLU TYR VAL ILE TYR ARG SEQRES 18 B 240 GLY GLU GLN ALA TYR PRO GLU TYR LEU ILE THR TYR GLN SEQRES 19 B 240 ILE MET ARG PRO GLU GLY HET ZN A2162 1 HET SO4 A2163 5 HET SO4 A2164 5 HET SO4 A2165 5 HET CDJ A2166 19 HET GOL A2167 6 HET ZN B2162 1 HET SO4 B2163 5 HET SO4 B2164 5 HET CDJ B2165 19 HET GOL B2166 6 HETNAM ZN ZINC ION HETNAM SO4 SULFATE ION HETNAM CDJ 5-AMINO-3-(4-CHLOROPHENYL)ISOQUINOLIN-1(2H)-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ZN 2(ZN 2+) FORMUL 4 SO4 5(O4 S 2-) FORMUL 7 CDJ 2(C15 H11 CL N2 O) FORMUL 8 GOL 2(C3 H8 O3) FORMUL 14 HOH *280(H2 O) HELIX 1 1 ASP A 962 THR A 975 1 14 HELIX 2 2 ASN A 1002 GLU A 1019 1 18 HELIX 3 3 PHE A 1035 GLY A 1043 1 9 HELIX 4 4 ASP A 1045 ALA A 1049 5 5 HELIX 5 5 ASN A 1064 GLN A 1070 1 7 HELIX 6 6 GLY A 1074 GLY A 1078 5 5 HELIX 7 7 ARG A 1143 GLU A 1145 5 3 HELIX 8 8 ASP B 962 THR B 975 1 14 HELIX 9 9 ASN B 1002 ASN B 1020 1 19 HELIX 10 10 PHE B 1035 GLY B 1043 1 9 HELIX 11 11 ASP B 1045 ALA B 1049 5 5 HELIX 12 12 ASN B 1064 GLN B 1070 1 7 HELIX 13 13 GLY B 1074 GLY B 1078 5 5 HELIX 14 14 ARG B 1143 GLU B 1145 5 3 SHEET 1 AA 5 ILE A 954 ASP A 957 0 SHEET 2 AA 5 TYR A 992 CYS A1001 -1 O LYS A 999 N ILE A 956 SHEET 3 AA 5 ALA A1147 ILE A1157 -1 O GLU A1150 N VAL A1000 SHEET 4 AA 5 ARG A1094 THR A1102 -1 O ARG A1094 N TYR A1155 SHEET 5 AA 5 GLU A1026 HIS A1031 -1 O ARG A1027 N VAL A1101 SHEET 1 AB 4 ILE A1059 ALA A1062 0 SHEET 2 AB 4 GLU A1138 ILE A1141 -1 O TYR A1139 N PHE A1061 SHEET 3 AB 4 SER A1124 PRO A1129 -1 O VAL A1125 N VAL A1140 SHEET 4 AB 4 SER A1106 SER A1111 1 O PHE A1107 N THR A1126 SHEET 1 BA 5 ILE B 954 ASP B 957 0 SHEET 2 BA 5 TYR B 992 CYS B1001 -1 O LYS B 999 N ILE B 956 SHEET 3 BA 5 ALA B1147 ILE B1157 -1 O GLU B1150 N VAL B1000 SHEET 4 BA 5 ARG B1094 THR B1102 -1 O ARG B1094 N TYR B1155 SHEET 5 BA 5 GLU B1026 HIS B1031 -1 O ARG B1027 N VAL B1101 SHEET 1 BB 4 ILE B1059 ALA B1062 0 SHEET 2 BB 4 GLU B1138 ILE B1141 -1 O TYR B1139 N PHE B1061 SHEET 3 BB 4 SER B1124 PRO B1129 -1 O VAL B1125 N VAL B1140 SHEET 4 BB 4 SER B1106 SER B1111 1 O PHE B1107 N THR B1126 LINK SG CYS A1081 ZN ZN A2162 1555 1555 2.26 LINK ND1 HIS A1084 ZN ZN A2162 1555 1555 2.19 LINK SG CYS A1089 ZN ZN A2162 1555 1555 2.18 LINK SG CYS A1092 ZN ZN A2162 1555 1555 2.34 LINK SG CYS B1081 ZN ZN B2162 1555 1555 2.37 LINK ND1 HIS B1084 ZN ZN B2162 1555 1555 2.02 LINK SG CYS B1089 ZN ZN B2162 1555 1555 2.06 LINK SG CYS B1092 ZN ZN B2162 1555 1555 2.32 SITE 1 AC1 4 CYS B1081 HIS B1084 CYS B1089 CYS B1092 SITE 1 AC2 4 CYS A1081 HIS A1084 CYS A1089 CYS A1092 SITE 1 AC3 6 ARG A 977 HIS A 979 ARG A 980 LYS A1067 SITE 2 AC3 6 ASN A1132 HOH A2033 SITE 1 AC4 5 HIS A1117 SER A1118 TYR A1142 ARG A1143 SITE 2 AC4 5 HOH A2146 SITE 1 AC5 6 ASN A 990 ARG A 991 PRO A1160 GLU A1161 SITE 2 AC5 6 HOH A2045 HOH A2048 SITE 1 AC6 7 ARG B 977 HIS B 979 ARG B 980 LYS B1067 SITE 2 AC6 7 GLN B1070 HOH B2031 HOH B2124 SITE 1 AC7 6 ASN B 990 ARG B 991 PRO B1160 GLU B1161 SITE 2 AC7 6 HOH B2037 HOH B2129 SITE 1 AC8 10 HIS A1031 GLY A1032 SER A1033 TYR A1050 SITE 2 AC8 10 TYR A1060 ALA A1062 LYS A1067 SER A1068 SITE 3 AC8 10 TYR A1071 GLU A1138 SITE 1 AC9 8 HIS B1031 GLY B1032 TYR B1050 TYR B1060 SITE 2 AC9 8 ALA B1062 LYS B1067 SER B1068 TYR B1071 SITE 1 BC1 3 PHE A1055 PHE A1107 GLN A1109 SITE 1 BC2 7 ARG B 977 GLU B 978 GLY B 983 GLY B 987 SITE 2 BC2 7 ILE B 988 PHE B 989 HOH B2025 CRYST1 90.690 98.150 118.000 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011027 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010188 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008475 0.00000